aseanostatin p5 has been researched along with 5-hydroxy-6,8,11,14-eicosatetraenoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, D; Collin, P; Madden, T; McConkey, D; Newman, RA; Sweeney-Gotsch, B; Yang, P | 1 |
| Collin, P; Hicks, ME; Newman, RA; Van Pelt, CS; Wright, KC; Yang, P | 1 |
2 other study(ies) available for aseanostatin p5 and 5-hydroxy-6,8,11,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Inhibition of proliferation of PC3 cells by the branched-chain fatty acid, 12-methyltetradecanoic acid, is associated with inhibition of 5-lipoxygenase.
Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Caspase 3; Caspases; Cell Division; Cyclooxygenase Inhibitors; Enzyme Activation; Enzyme Inhibitors; Fatty Acids; Female; Flow Cytometry; Growth Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Lipoxygenase Inhibitors; Male; Microscopy, Electron, Scanning; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 2003 |
Evaluation of targeted arterial delivery of the branched chain fatty acid 12-methyltetradecanoic acid as a novel therapy for solid tumors.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Antineoplastic Agents; Arachidonate 5-Lipoxygenase; Blotting, Western; Caspase 3; Caspases; Cell Line, Tumor; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Fatty Acids; Humans; Hydroxyeicosatetraenoic Acids; Immunohistochemistry; Lipoxygenase Inhibitors; Neoplasm Transplantation; Neoplasms; Rabbits; Tissue Fixation | 2005 |